HUP9901254A3 - Non-dendritic backbone peptide carrier - Google Patents
Non-dendritic backbone peptide carrierInfo
- Publication number
- HUP9901254A3 HUP9901254A3 HU9901254A HUP9901254A HUP9901254A3 HU P9901254 A3 HUP9901254 A3 HU P9901254A3 HU 9901254 A HU9901254 A HU 9901254A HU P9901254 A HUP9901254 A HU P9901254A HU P9901254 A3 HUP9901254 A3 HU P9901254A3
- Authority
- HU
- Hungary
- Prior art keywords
- peptide carrier
- backbone peptide
- dendritic backbone
- dendritic
- carrier
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/115—Paramyxoviridae, e.g. parainfluenza virus
- G01N2333/12—Mumps virus; Measles virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
- G01N2333/445—Plasmodium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/545—IL-1
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/555—Interferons [IFN]
- G01N2333/57—IFN-gamma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK39896 | 1996-04-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9901254A2 HUP9901254A2 (hu) | 1999-07-28 |
HUP9901254A3 true HUP9901254A3 (en) | 2001-10-29 |
Family
ID=8093081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9901254A HUP9901254A3 (en) | 1996-04-03 | 1997-04-03 | Non-dendritic backbone peptide carrier |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0896582A1 (fr) |
JP (1) | JP2001502658A (fr) |
KR (1) | KR20000005429A (fr) |
CN (1) | CN1215404A (fr) |
AU (1) | AU704502B2 (fr) |
CA (1) | CA2251464A1 (fr) |
HU (1) | HUP9901254A3 (fr) |
NO (1) | NO984644L (fr) |
NZ (1) | NZ331596A (fr) |
WO (1) | WO1997038011A1 (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103239A (en) | 1996-08-09 | 2000-08-15 | Cel-Sci Corporation | Modified HGP-30 heteroconjugates, compositions and methods of use |
US6251866B1 (en) | 1997-08-05 | 2001-06-26 | Watson Laboratories, Inc. | Conjugates targeted to the interleukin-2 receptor |
US6582700B1 (en) * | 1997-11-18 | 2003-06-24 | Medical University Of South Carolina | Linear antigen supporting units |
US6472367B1 (en) * | 1998-05-05 | 2002-10-29 | Adherex Technologies, Inc. | Compounds and methods for modulating OB-cadherin mediated cell adhesion |
US7481999B2 (en) | 1998-05-05 | 2009-01-27 | Adherex Technologies, Inc. | Compounds and methods for modulating OB-cadherin-mediated function |
EP1246597B1 (fr) * | 1999-08-03 | 2015-01-14 | The Ohio State University | Polypeptides et polynucleotides ameliorant la reactivite immunitaire a la proteine her-2 |
GB9930591D0 (en) * | 1999-12-23 | 2000-02-16 | Univ London | Component for vaccine |
EP1255568A2 (fr) * | 2000-02-18 | 2002-11-13 | Watson Pharmaceuticals, Inc. | Conjugues cibles sur des recepteurs cibles |
CN100553636C (zh) | 2000-08-04 | 2009-10-28 | Dmi生物科学公司 | 二酮基哌嗪和包含它们的组合物的使用方法 |
US7303907B2 (en) | 2001-01-08 | 2007-12-04 | Health Protection Agency | Degradation and detection of TSE infectivity |
JP4421900B2 (ja) * | 2002-04-09 | 2010-02-24 | ザ スクリップス リサーチ インスティテュート | モチーフ・グラフトされたハイブリッドポリペプチドおよびその使用 |
EP1534746A2 (fr) * | 2002-08-23 | 2005-06-01 | Copenhagen Biotech Assets APS | Composes peptidiques composites destines au diagnostic et au traitement de maladies induites par des proteines prions |
WO2004048411A2 (fr) | 2002-11-14 | 2004-06-10 | Adherex Technologies, Inc. | Composes et techniques destines a moduler des fonctions de cadherines non classiques |
US7354589B2 (en) * | 2003-01-16 | 2008-04-08 | The Wistar Institute | Multiple antigenic agents and methods for using the same |
CN103191409A (zh) | 2003-05-15 | 2013-07-10 | Dmi生物科学公司 | T-细胞介导的疾病的治疗 |
US7740860B2 (en) | 2005-03-29 | 2010-06-22 | The Wistar Institute | Composition and method for preventing or treating a virus infection |
WO2006138675A2 (fr) | 2005-06-15 | 2006-12-28 | The Ohio State University Research Foundation | Peptides her-2 |
KR100787393B1 (ko) * | 2006-03-23 | 2007-12-21 | 학교법인 한림대학교 | 세포 도입성 fk506 결합 단백질의 융합 단백질 |
US8217047B2 (en) | 2008-05-27 | 2012-07-10 | Dmi Acquisition Corp. | Therapeutic methods and compounds |
EP4071169A2 (fr) | 2008-08-25 | 2022-10-12 | Dana Farber Cancer Institute, Inc. | Épitope d'hémagglutinine de la grippe conservé et anticorps associés |
US20100234283A1 (en) | 2009-02-04 | 2010-09-16 | The Ohio State University Research Foundation | Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
CN102297968B (zh) * | 2010-06-28 | 2013-10-30 | 程小星 | 辅助诊断结核病的试剂盒 |
EP2613786A4 (fr) | 2010-09-07 | 2013-10-23 | Dmi Acquisition Corp | Traitement de maladies |
JP2014530063A (ja) | 2011-10-10 | 2014-11-17 | アンピオ ファーマシューティカルズ,インコーポレイテッド | 免疫寛容が高められた埋込み型医療用デバイス、ならびに製造方法および埋込み方法 |
PL2766029T3 (pl) | 2011-10-10 | 2020-08-24 | Ampio Pharmaceuticals, Inc. | Leczenie choroby zwyrodnieniowej stawów |
KR20140095479A (ko) | 2011-10-28 | 2014-08-01 | 앰피오 파마슈티컬스 인코퍼레이티드 | 비염의 치료 |
US9808454B2 (en) | 2013-03-15 | 2017-11-07 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
CN104231048B (zh) * | 2013-06-05 | 2017-05-24 | 财团法人工业技术研究院 | 生发胜肽及药物组合物 |
TWI516272B (zh) | 2013-06-05 | 2016-01-11 | 財團法人工業技術研究院 | 應用於生髮之方法及醫藥組成物 |
AU2015305611B2 (en) | 2014-08-18 | 2020-04-23 | Ampio Pharmaceuticals, Inc. | Treatment of joint conditions |
US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
US11684660B2 (en) * | 2017-03-28 | 2023-06-27 | Ohio State Innovation Foundation | Human PD1 peptide vaccines and uses thereof |
KR20220092557A (ko) * | 2019-10-29 | 2022-07-01 | 위스콘신 얼럼나이 리서어치 화운데이션 | 펩티드-나노입자 접합체 |
CN112851755B (zh) * | 2021-01-13 | 2023-09-01 | 中国人民解放军军事科学院军事医学研究院 | 一种线性脂肽化合物及其制备方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2217319A (en) * | 1988-04-19 | 1989-10-25 | Synpharm Ltd | Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi |
GB9215780D0 (en) * | 1992-07-24 | 1992-09-09 | Univ London Pharmacy | Peptide compounds |
US5674977A (en) * | 1993-02-05 | 1997-10-07 | The Ontario Cancer Institute | Branched synthetic peptide conjugate |
CA2169284A1 (fr) * | 1993-08-11 | 1995-02-16 | Philip E. Dawson | Proteine synthetique obtenue a l'aide d'une matrice |
GB2282813A (en) * | 1993-10-15 | 1995-04-19 | Merck & Co Inc | Annular antigen scaffolds comprising thioether linkages |
JP3872813B2 (ja) * | 1994-05-18 | 2007-01-24 | エス.ピー.アイ. シンセティック ペプチデス インコーポレイテッド | ヘテロダイマーポリペプチド免疫原キャリア組成物および方法 |
-
1997
- 1997-04-03 AU AU25679/97A patent/AU704502B2/en not_active Ceased
- 1997-04-03 WO PCT/DK1997/000146 patent/WO1997038011A1/fr not_active Application Discontinuation
- 1997-04-03 KR KR1019980708186A patent/KR20000005429A/ko not_active Application Discontinuation
- 1997-04-03 CA CA002251464A patent/CA2251464A1/fr not_active Abandoned
- 1997-04-03 JP JP09535761A patent/JP2001502658A/ja not_active Withdrawn
- 1997-04-03 NZ NZ331596A patent/NZ331596A/xx unknown
- 1997-04-03 HU HU9901254A patent/HUP9901254A3/hu unknown
- 1997-04-03 CN CN97193489A patent/CN1215404A/zh active Pending
- 1997-04-03 EP EP97917281A patent/EP0896582A1/fr not_active Withdrawn
-
1998
- 1998-10-02 NO NO984644A patent/NO984644L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2567997A (en) | 1997-10-29 |
JP2001502658A (ja) | 2001-02-27 |
AU704502B2 (en) | 1999-04-22 |
CN1215404A (zh) | 1999-04-28 |
NO984644D0 (no) | 1998-10-02 |
EP0896582A1 (fr) | 1999-02-17 |
NZ331596A (en) | 1999-07-29 |
NO984644L (no) | 1998-12-03 |
CA2251464A1 (fr) | 1997-10-16 |
WO1997038011A1 (fr) | 1997-10-16 |
KR20000005429A (ko) | 2000-01-25 |
HUP9901254A2 (hu) | 1999-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ331596A (en) | Non-dendritic backbone peptide carrier | |
IL120027A0 (en) | Carrier | |
GB2315260B (en) | Wafer carrier | |
HUP9901455A3 (en) | Somatostatin peptides | |
GB2309673B (en) | Container carrier | |
GB9703787D0 (en) | Improved label | |
HK1014964A1 (en) | Somatostatin peptides. | |
GB2348634B (en) | Wafer carrier | |
TW306148U (en) | Buoy | |
ZA978475B (en) | Sulphide containing peptides. | |
AU133050S (en) | Carrier | |
GB9613705D0 (en) | Novel peptides | |
GB2324520B (en) | Carrier | |
CA79530S (en) | Carrier | |
GB9613646D0 (en) | Hand held plastic-bags carrier | |
AU128536S (en) | Bag carrier | |
GB9608430D0 (en) | Peptides | |
GB9606765D0 (en) | Peptides | |
GB9626362D0 (en) | Peptides | |
GB9612648D0 (en) | Peptides | |
GB9625227D0 (en) | Peptides | |
SG55039A1 (en) | Peptides | |
GB9605904D0 (en) | Peptides | |
GB9600919D0 (en) | Folding back carrier | |
SI0835263T1 (en) | Somatostatin peptides |